Log In | Register
Recently, the FDA issued a warning letter to the drug company Salix Pharmaceuticals stating that the company's marketing materials for its generic version of Reglan, Metozolv ODT, were misleading.
FDA Letter Highlights Metoclopramide Label Inaccuracies
Seeded on Tue May 11, 2010 9:45 AM EDT
- Enjoy this article? Help vote it up the 'Vine.
- Public Discussion (0)
You're in Easy Mode. If you prefer, you can use XHTML Mode instead. |
As a new user, you may notice a few temporary content restrictions. Click here for more info.
